Rexnord Corp (RXN):企業の財務・戦略的SWOT分析

◆英語タイトル:Rexnord Corp (RXN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0423
◆発行会社(調査会社):GlobalData
◆発行日:2019年12月
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Industrial Goods and Machinery
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Rexnord Corp (RXN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Rexnord Corp (Rexnord) offers process and motion control, and water management products. The company designs, manufactures, markets and services mechanical components, and water flow control and conservation products. Its product portfolio includes motion control products, aerospace components, and shaft management products; and water distribution and drainage, finish plumbing, professional grade water control and safety, and site works products. The company markets its products and services under Falk, Rexnord, FlatTop, Rex, Link-Belt, Zurn, Wilkins brands. It serves cement and aggregates, energy and power generation, mining, agriculture, petrochemical, aerospace, forest and wood products, food and beverage, and general industrial and automation applications across North America, Europe, and other regions. Rexnord is headquartered in Milwaukee, Wisconsin, the US.

Rexnord Corp Key Recent Developments

Jan 30,2019: Rexnord reports Q3 FY2019 financial results and increases FY2019 operating outlook
Jul 30,2018: Rexnord reports Q1 FY2019 financial results and increases FY2019 operating outlook

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Rexnord Corp – Key Facts
Rexnord Corp – Key Employees
Rexnord Corp – Key Employee Biographies
Rexnord Corp – Major Products and Services
Rexnord Corp – History
Rexnord Corp – Company Statement
Rexnord Corp – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Rexnord Corp – Business Description
Business Segment: Process & Motion Control
Overview
Performance
Key Stats
Business Segment: Water Management
Overview
Performance
Key Stats
Geographical Segment: Europe (Process & Motion Control)
Performance
Geographical Segment: Rest of world (Process & Motion Control)
Performance
Geographical Segment: Rest of world (Water Management)
Performance
Geographical Segment: United States and Canada (Process & Motion Control)
Performance
Geographical Segment: United States and Canada (Water Management)
Performance
Rexnord Corp – Corporate Strategy
Rexnord Corp – SWOT Analysis
SWOT Analysis – Overview
Rexnord Corp – Strengths
Rexnord Corp – Weaknesses
Rexnord Corp – Opportunities
Rexnord Corp – Threats
Rexnord Corp – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Rexnord Corp, Recent Deals Summary
Section 4 – Company’s Recent Developments
Jan 30, 2019: Rexnord reports Q3 FY2019 financial results and increases FY2019 operating outlook
Jul 30, 2018: Rexnord reports Q1 FY2019 financial results and increases FY2019 operating outlook
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Rexnord Corp, Key Facts
Rexnord Corp, Key Employees
Rexnord Corp, Key Employee Biographies
Rexnord Corp, Major Products and Services
Rexnord Corp, History
Rexnord Corp, Subsidiaries
Rexnord Corp, Key Competitors
Rexnord Corp, Ratios based on current share price
Rexnord Corp, Annual Ratios
Rexnord Corp, Annual Ratios (Cont...1)
Rexnord Corp, Annual Ratios (Cont...2)
Rexnord Corp, Interim Ratios
Rexnord Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Rexnord Corp, Performance Chart (2015 - 2019)
Rexnord Corp, Ratio Charts

★海外企業調査レポート[Rexnord Corp (RXN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Johnson & Johnson (JNJ)-製薬・医療分野:企業M&A・提携分析
    Summary Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infec …
  • U.S. Department of Health and Human Services-製薬・医療分野:企業M&A・提携分析
    Summary U.S. Department of Health and Human Services (HHS) is a healthcare service provider that offers patient care and support services. The organization’s service areas include health insurance marketplace, mental health, food safety, fighting HIV or AIDS, supporting military families, statistics …
  • Zavante Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a developer of novel therapies for the treatment of infectious diseases. The company offers drugs for the treatment of diseases that affect patients in the hospital setting. Its lead product candidate ZOLYD, is an investi …
  • ThyssenKrupp AG:企業のM&A・事業提携・投資動向
    ThyssenKrupp AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ThyssenKrupp AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Nanosonics Ltd (NAN)-医療機器分野:企業M&A・提携分析
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Systemax Inc.:企業の戦略・SWOT・財務情報
    Systemax Inc. - Strategy, SWOT and Corporate Finance Report Summary Systemax Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Allegra Orthopaedics Ltd (AMT):企業の財務・戦略的SWOT分析
    Allegra Orthopaedics Ltd (AMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • EPI Ingredients:企業の戦略・SWOT・財務分析
    EPI Ingredients - Strategy, SWOT and Corporate Finance Report Summary EPI Ingredients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Calypso Biotech SA-製薬・医療分野:企業M&A・提携分析
    Summary Calypso Biotech SA (Calypso) is a biopharmaceutical company that develops antibody therapies. The company’s pipeline products include CALY-0001 and CALY-0002. Its CALY-0001 therapeutic antibody is used in the treatment of Crohn’s disease; and CALY-0002 a humanized monoclonal antibody used in …
  • National Bank of Kuwait S.A.K.:戦略・SWOT・企業財務分析
    National Bank of Kuwait S.A.K. - Strategy, SWOT and Corporate Finance Report Summary National Bank of Kuwait S.A.K. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Gainesville Regional Utilities:企業の戦略的SWOT分析
    Gainesville Regional Utilities - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Goodrich Petroleum Corp (GDP):企業の財務・戦略的SWOT分析
    Goodrich Petroleum Corp (GDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Opiant Pharmaceuticals Inc (OPNT):医療機器:M&Aディール及び事業提携情報
    Summary Opiant Pharmaceuticals Inc (Opiant), formerly, Lightlake Therapeutics Inc is a specialty pharmaceutical company that develops pharmacological treatments for substance use, addiction and eating disorders. It focuses on developing treatments to reverse opioid overdoses, for overweight and obes …
  • Caisse de depot et placement du Quebec:企業の戦略・SWOT・財務分析
    Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report Summary Caisse de depot et placement du Quebec - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • ABF Ingredients Ltd:企業の戦略・SWOT・財務情報
    ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report Summary ABF Ingredients Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Koch Enterprises, Inc.:企業の戦略・SWOT・財務分析
    Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Koch Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Associated Electric Cooperative Inc.:発電所・企業SWOT分析
    Associated Electric Cooperative Inc. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • CSE Global Limited (544):企業の財務・戦略的SWOT分析
    CSE Global Limited (544) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • genOway SA (ALGEN):製薬・医療:M&Aディール及び事業提携情報
    Summary genOway SA (genOway) is a biotechnology company that develops genetically modified mouse, rat and cellular models for pharmaceutical companies and research institutes. The company develops several technology platforms such as safe DNA transgenesis, quick knock-in, safe in vivo RNAi and safe …
  • Fabasoft Ag:企業の戦略・SWOT・財務分析
    Fabasoft Ag - Strategy, SWOT and Corporate Finance Report Summary Fabasoft Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆